NAT8B Antikörper (AA 107-156)
Kurzübersicht für NAT8B Antikörper (AA 107-156) (ABIN6741652)
Target
Alle NAT8B Antikörper anzeigenReaktivität
Wirt
Klonalität
Konjugat
Applikation
-
-
Bindungsspezifität
- AA 107-156
-
Spezifität
- Human NAT8B
-
Homologie
- Percent identity by BLAST analysis: Human (100%).
-
Aufreinigung
- Immunoaffinity purified
-
Immunogen
-
Synthetic peptide located between aa107-156 of human NAT8B (Q9UHF3, NP_057431). Percent identity by BLAST analysis: Human, Gorilla, Bovine, Horse, Pig (100%), Orangutan (92%), Gibbon, Opossum, Platypus (84%), Mouse, Rat (78%).
Type of Immunogen: Synthetic peptide -
Isotyp
- IgG
-
-
anti-N-Acetyltransferase 8B (GCN5-Related, Putative, Gene/pseudogene) (NAT8B) (AA 75-165) antibody
NAT8B Reaktivität: Human WB, IHC Wirt: Kaninchen Polyclonal unconjugated
anti-N-Acetyltransferase 8B (GCN5-Related, Putative, Gene/pseudogene) (NAT8B) antibodyNAT8B Reaktivität: Human, Maus, Ratte IHC Wirt: Kaninchen Polyclonal unconjugated
anti-N-Acetyltransferase 8B (GCN5-Related, Putative, Gene/pseudogene) (NAT8B) (AA 83-179) antibodyNAT8B Reaktivität: Human WB, ELISA Wirt: Maus Monoclonal 3B6 unconjugated
-
-
Applikationshinweise
-
Approved: WB (0.2 - 1 μg/mL)
Usage: Western Blot: Suggested dilution at 1 μg/mL in 5 % skim milk / PBS buffer, and HRP conjugated anti-Rabbit IgG should be diluted in 1: 50,000 - 100,000 as second antibody. ELISA titer in peptide based assay: 1:62500. -
Kommentare
-
Target Species of Antibody: Human
-
Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
-
-
Format
- Lyophilized
-
Rekonstitution
- Distilled water
-
Konzentration
- Lot specific
-
Buffer
- Lyophilized from PBS with 2 % sucrose
-
Handhabung
- Avoid repeat freeze-thaw cycles.
-
Lagerung
- 4 °C,-20 °C
-
Informationen zur Lagerung
-
Long term: -20°C, the use of 50% glycerol is recommended if storing aliquots in -20°C for long term use (up to 1 year)
Short term (less than 1 week): 4°C. Avoid freeze-thaw cycles.
-
-
-
